Yahoo! Tech (nprofile…834n)
https://media.zenfs.com/en/reuters-finance.com/950cc4bd778fc555319906ae72c8417b
https://finance.yahoo.com/news/pfizer-signs-6-billion-licensing-003547040.html
Yahoo! Tech
npub1hr…qj2rr
2025-05-20 00:42:18
Author Public Key
npub1hrmeelmxktje8vy2t6axvt5ae0emvfk4v5hxrvaceky4pfmn8guqkqj2rrPublished at
2025-05-20 00:42:18Event JSON
{
"id": "aa05170651070a157dcb25d7f26b2e6cb1e0882f1823a981cccaa567d3d28243",
"pubkey": "b8f79cff66b2e593b08a5eba662e9dcbf3b626d5652e61b3b8cd8950a7733a38",
"created_at": 1747701738,
"kind": 1,
"tags": [
[
"r",
"https://finance.yahoo.com/news/pfizer-signs-6-billion-licensing-003547040.html"
],
[
"subject",
"Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug"
],
[
"published_at",
"1747701347"
],
[
"image",
"https://media.zenfs.com/en/reuters-finance.com/950cc4bd778fc555319906ae72c8417b"
],
[
"p",
"b8f79cff66b2e593b08a5eba662e9dcbf3b626d5652e61b3b8cd8950a7733a38",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://media.zenfs.com/en/reuters-finance.com/950cc4bd778fc555319906ae72c8417b"
],
[
"t",
"Technology:perspective"
],
[
"summary",
"Pfizer has signed a licensing agreement worth up to $6 billion with 3SBio Inc to develop, manufacture, and commercialize a drug undergoing trials for the treatment of certain types of cancer and tumours. The agreement aims to accelerate the development and availability of the drug, which is currently in clinical trials."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqhrmeelmxktje8vy2t6axvt5ae0emvfk4v5hxrvaceky4pfmn8guq4j834n\nhttps://media.zenfs.com/en/reuters-finance.com/950cc4bd778fc555319906ae72c8417b\n\nhttps://finance.yahoo.com/news/pfizer-signs-6-billion-licensing-003547040.html",
"sig": "3937b5fc81b39c55f61564db28257474e68f2b877d203d59ecfa0bed96ca01018bdb459baae06eae613728bb867149717de57886c694977f088328f4f85cfc34"
}